MedPath

Assessing the Effects of Increased Mitochondrial Function Exercise Training on Muscle Performance

Not Applicable
Terminated
Conditions
Impaired Mitochondrial Function, Muscle Performance
Registration Number
NCT03325491
Lead Sponsor
University of Exeter
Brief Summary

As people grow older skeletal muscle gradually becomes smaller and weaker, causing reduced mobility and quality of life. To understand and reverse this negative process investigators need to find new ways of improving the ability of muscle to perform physical activity. There is some evidence that supplements may improve how the mitochondria work, and investigators want to explore this idea in more detail. This is possible by measuring how the muscles work and respond to exercise before and after taking the supplement alongside an aerobic (i.e. cycling) and resistance (i.e. weight lifting) exercise programme. This will give us the basic information investigators would need to see if this is a useful idea.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
2
Inclusion Criteria
  • Male
  • Age between 65-75 years
  • Body mass index between 19-29
  • No active cardiovascular or metabolic disease
  • No active respiratory disease
  • No current musculoskeletal injuries
  • A sedentary lifestyle (i.e. does not engage in strenuous, planned physical activity)
  • The ability to give informed consent
Exclusion Criteria
  • Currently taking a statin drug or NSAIDs
  • Have a current peptic ulcer
  • Have any renal impairment
  • Have a known hypersensitivity to Acipimox
  • Suffer from vertigo
  • Smoker

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in mitochondrial functionBaseline, 3 weeks, 6 weeks

Mitochondria will be extracted from muscle samples immediately post-biopsy (biopsies taken baseline, week 3 and week 6) and analysed for content and subsequently for oxidative respiratory function using the Oroboros technique, and maximal rates of Adenosine Triphosphate (ATP) production.

Secondary Outcome Measures
NameTimeMethod
Chronic changes in habitual muscle protein synthetic ratesBaseline, 3 weeks and 6 weeks

Baseline saliva samples then frequent saliva samples over 6 weeks following oral ingestion of the stable isotope deuterium oxide (D2O, or 'heavy water') will be analysed by gas-chromatography-pyrolysis-isotope ratio mass-spectrometry. analysis. Muscle samples collected at baseline, 3 weeks, 6 weeks will also be analysed by gas-chromatography-pyrolysis-isotope ratio mass-spectrometry

Trial Locations

Locations (1)

NIHR Exeter Clinical Research Facility

🇬🇧

Exeter, Devon, United Kingdom

NIHR Exeter Clinical Research Facility
🇬🇧Exeter, Devon, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.